Simplex Trading’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-41,900
| Closed | -$18K | – | 10943 |
|
|
2022
Q3 | $18K | Buy |
41,900
+19,100
| +84% | +$14.3K | ﹤0.01% | 7660 |
|
|
2022
Q2 | $19K | Buy |
22,800
+4,700
| +26% | +$7.89K | ﹤0.01% | 7695 |
|
|
2022
Q1 | $99K | Buy |
18,100
+17,000
| +1,545% | +$108K | ﹤0.01% | 6169 |
|
|
2021
Q4 | $10K | Sell |
1,100
-1,800
| -62% | -$25K | ﹤0.01% | 9081 |
|
|
2021
Q3 | $75K | Hold |
2,900
| – | – | ﹤0.01% | 7024 |
|
|
2021
Q2 | $70K | Buy |
2,900
+2,785
| +2,422% | +$69.7K | ﹤0.01% | 7218 |
|
|
2021
Q1 | $304K | Sell |
115
-329
| -74% | -$4.8K | ﹤0.01% | 4128 |
|
|
2020
Q4 | $336K | Buy |
+444
| New | +$2.64K | ﹤0.01% | 3936 |
|
|
2020
Q3 | – | Sell |
-2
| Closed | -$1K | – | 8769 |
|
|
2020
Q2 | $1K | Sell |
2
-1
| -33% | -$6 | ﹤0.01% | 7445 |
|
|
2020
Q1 | $1K | Sell |
3
-2
| -40% | -$15 | ﹤0.01% | 7449 |
|
|
2019
Q4 | $3K | Buy |
+5
| New | +$48 | ﹤0.01% | 6918 |
|
Simplex Trading's RUBY Position: Q2 2023 in Review
Simplex Trading sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2023, closing a stake of 3,856 shares.
Simplex Trading first reported a position in RUBY in Q1 2021 and held it in 7 quarters. The position peaked at $585K in Q1 2022. 0 funds tracked by Wall St. Rank hold RUBY as of Q2 2023.
- Simplex Trading reported no remaining Rubius Therapeutics, Inc position as of Q2 2023 after selling out during the quarter.
- Simplex Trading sold 3,856 Rubius Therapeutics, Inc shares in Q2 2023.
- Simplex Trading first reported a position in Rubius Therapeutics, Inc in Q1 2021 and held it in 7 quarters.
- Simplex Trading's Rubius Therapeutics, Inc position peaked at $585K in Q1 2022.
- 0 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2023.
Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.